BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32124083)

  • 1. Cyclocreatine Transport by SLC6A8, the Creatine Transporter, in HEK293 Cells, a Human Blood-Brain Barrier Model Cell, and CCDSs Patient-Derived Fibroblasts.
    Uemura T; Ito S; Masuda T; Shimbo H; Goto T; Osaka H; Wada T; Couraud PO; Ohtsuki S
    Pharm Res; 2020 Mar; 37(3):61. PubMed ID: 32124083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency.
    Kurosawa Y; Degrauw TJ; Lindquist DM; Blanco VM; Pyne-Geithman GJ; Daikoku T; Chambers JB; Benoit SC; Clark JF
    J Clin Invest; 2012 Aug; 122(8):2837-46. PubMed ID: 22751104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal N-Glycosylation of a Novel Missense Creatine Transporter Mutant, G561R, Associated with Cerebral Creatine Deficiency Syndromes Alters Transporter Activity and Localization.
    Uemura T; Ito S; Ohta Y; Tachikawa M; Wada T; Terasaki T; Ohtsuki S
    Biol Pharm Bull; 2017; 40(1):49-55. PubMed ID: 28049948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an animal model of disease for toxicology enables identification of a juvenile no observed adverse effect level for cyclocreatine in creatine transporter deficiency.
    Do MT; Cavagnaro J; Butt M; Terse PS; McKew JC
    Regul Toxicol Pharmacol; 2021 Jul; 123():104939. PubMed ID: 33961952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.
    Gorshkov K; Wang AQ; Sun W; Fisher E; Frigeni M; Singleton M; Thorne N; Class B; Huang W; Longo N; Do MT; Ottinger EA; Xu X; Zheng W
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00525. PubMed ID: 31859463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of Intrinsic Creatine Transporter (Slc6a8) Activity and Creatine Transport Function of Leukocytes in Rats.
    Taii A; Tachikawa M; Ohta Y; Hosoya KI; Terasaki T
    Biol Pharm Bull; 2020; 43(3):474-479. PubMed ID: 32115505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-Scale Quantitative Comparison of Plasma Transmembrane Proteins between Two Human Blood-Brain Barrier Model Cell Lines, hCMEC/D3 and HBMEC/ciβ.
    Masuda T; Hoshiyama T; Uemura T; Hirayama-Kurogi M; Ogata S; Furukawa A; Couraud PO; Furihata T; Ito S; Ohtsuki S
    Mol Pharm; 2019 May; 16(5):2162-2171. PubMed ID: 30983357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elucidation of Disease Mechanisms Based on Transport Function at Tissue Barriers and Challenges in Drug Development].
    Ito S
    Yakugaku Zasshi; 2019; 139(4):497-503. PubMed ID: 30930376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The blood-brain barrier transport and cerebral distribution of guanidinoacetate in rats: involvement of creatine and taurine transporters.
    Tachikawa M; Kasai Y; Yokoyama R; Fujinawa J; Ganapathy V; Terasaki T; Hosoya K
    J Neurochem; 2009 Oct; 111(2):499-509. PubMed ID: 19682207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA sequencing of creatine transporter (SLC6A8) deficient fibroblasts reveals impairment of the extracellular matrix.
    Nota B; Ndika JD; van de Kamp JM; Kanhai WA; van Dooren SJ; van de Wiel MA; Pals G; Salomons GS
    Hum Mutat; 2014 Sep; 35(9):1128-35. PubMed ID: 24962355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional assessment of creatine transporter in control and X-linked SLC6A8-deficient fibroblasts.
    Joncquel-Chevalier Curt M; Bout MA; Fontaine M; Kim I; Huet G; Bekri S; Morin G; Moortgat S; Moerman A; Cuisset JM; Cheillan D; Vamecq J
    Mol Genet Metab; 2018 Apr; 123(4):463-471. PubMed ID: 29478817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and possible role of creatine transporter in the brain and at the blood-cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant.
    Tachikawa M; Fujinawa J; Takahashi M; Kasai Y; Fukaya M; Sakai K; Yamazaki M; Tomi M; Watanabe M; Sakimura K; Terasaki T; Hosoya K
    J Neurochem; 2008 Nov; 107(3):768-78. PubMed ID: 18761709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices.
    Enrico A; Patrizia G; Luisa P; Alessandro P; Gianluigi L; Carlo G; Maurizio B
    J Integr Neurosci; 2013 Jun; 12(2):285-97. PubMed ID: 23869866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase.
    Mulvaney PT; Stracke ML; Nam SW; Woodhouse E; O'Keefe M; Clair T; Liotta LA; Khaddurah-Daouk R; Schiffmann E
    Int J Cancer; 1998 Sep; 78(1):46-52. PubMed ID: 9724093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-to-retina transport of creatine via creatine transporter (CRT) at the rat inner blood-retinal barrier.
    Nakashima T; Tomi M; Katayama K; Tachikawa M; Watanabe M; Terasaki T; Hosoya K
    J Neurochem; 2004 Jun; 89(6):1454-61. PubMed ID: 15189348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain.
    Ohtsuki S; Tachikawa M; Takanaga H; Shimizu H; Watanabe M; Hosoya K; Terasaki T
    J Cereb Blood Flow Metab; 2002 Nov; 22(11):1327-35. PubMed ID: 12439290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of the promoter regions from the parent and paralogous creatine transporter genes.
    Ndika JD; Lusink V; Beaubrun C; Kanhai W; Martinez-Munoz C; Jakobs C; Salomons GS
    Gene; 2014 Jan; 533(2):488-93. PubMed ID: 24144841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.
    Takahashi Y; Nishimura T; Higuchi K; Noguchi S; Tega Y; Kurosawa T; Deguchi Y; Tomi M
    Pharm Res; 2018 Oct; 35(12):246. PubMed ID: 30374619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology.
    Stockler S; Schutz PW; Salomons GS
    Subcell Biochem; 2007; 46():149-66. PubMed ID: 18652076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of analgo of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine).
    Griffiths GR; Walker JB
    J Biol Chem; 1976 Apr; 251(7):2049-54. PubMed ID: 1270421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.